financetom
Business
financetom
/
Business
/
Rhythm Pharmaceuticals Insider Sold Shares Worth $1,201,062, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rhythm Pharmaceuticals Insider Sold Shares Worth $1,201,062, According to a Recent SEC Filing
Jul 11, 2025 1:50 PM

04:40 PM EDT, 07/11/2025 (MT Newswires) -- Pamela J. Cramer, Chief Human Resources Officer, on July 09, 2025, sold 15,572 shares in Rhythm Pharmaceuticals ( RYTM ) for $1,201,062. Following the Form 4 filing with the SEC, Cramer has control over a total of 19,209 common shares of the company, with 19,209 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649904/000110465925067427/xslF345X05/tm2520691-1_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
(Reuters) -U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare Conference on Monday. We are all in ... we are building our teams ... We are recruiting experts in obesity over the last, let's...
What's Going On With 22nd Century Group Shares Monday?
What's Going On With 22nd Century Group Shares Monday?
Jan 13, 2025
22nd Century Group, Inc. ( XXII ) stock is moving higher on Monday after the company announced its readiness to support the Food and Drug Administration’s (FDA) proposed standard to mandate reduced nicotine content in cigarettes. What To Know: The proposed standard aligns with the FDA’s long-standing effort to drastically reduce nicotine levels in cigarettes and is consistent with the...
Looking At McDonald's's Recent Unusual Options Activity
Looking At McDonald's's Recent Unusual Options Activity
Jan 13, 2025
Deep-pocketed investors have adopted a bearish approach towards McDonald's , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MCD usually suggests something big is about to happen. We gleaned this information from our observations today...
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Pfizer going 'all in' on obesity drug development, CEO Bourla says
Jan 13, 2025
Jan 13 (Reuters) - U.S. drugmaker Pfizer ( PFE ) is going all in to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Exeuctive Officer Albert Bourla said at the JPMorgan Healthcare conference on Monday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved